Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;118:33-41
Published online before print June 16, 2008, doi: 10.1161/CIRCULATIONAHA.107.721878
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
118/1/33    most recent
CIRCULATIONAHA.107.721878v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Pande, R. L.
Right arrow Articles by Creager, M. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pande, R. L.
Right arrow Articles by Creager, M. A.
Related Collections
Right arrow Epidemiology
Right arrow Peripheral vascular disease
Right arrow Risk Factors
Right arrowRelated Article

(Circulation. 2008;118:33-41.)
© 2008 American Heart Association, Inc.


Epidemiology

Association of Insulin Resistance and Inflammation With Peripheral Arterial Disease

The National Health and Nutrition Examination Survey, 1999 to 2004

Reena L. Pande, MD; Todd S. Perlstein, MD, MMSc; Joshua A. Beckman, MD, MSc; Mark A. Creager, MD

From the Department of Medicine, Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.

Correspondence to Reena L. Pande, MD, Brigham and Women’s Hospital, Cardiovascular Division, 75 Francis St, A Bldg, 3rd Floor, Boston, MA 02115. E-mail rpande{at}partners.org

Received June 15, 2007; accepted August 24, 2008.

Background— Although the role of inflammation in the pathophysiology of peripheral arterial disease (PAD) is well established, the contribution of insulin resistance (IR) to PAD is less clear. We hypothesized that IR is associated with PAD and that the presence of IR would influence the association between C-reactive protein (CRP) and PAD, an association established predominantly in healthy individuals.

Methods and Results— We analyzed data from 3242 adults in the National Health and Nutrition Examination Survey (NHANES) 1999 to 2004 who underwent measurement of ankle brachial index, CRP, and fasting glucose and insulin, enabling calculation of homeostasis model of IR (HOMA-IR). Odds ratios (ORs) and 95% CIs were estimated by logistic regression. The mean prevalence of PAD (defined as an ankle brachial index ≤0.9) was 5.5% (SE, 0.47%). HOMA-IR was independently associated with PAD (OR, 2.06; 95% CI, 1.1 to 4.0; P=0.03 for quartile 4, P for trend across quartiles=0.047) after adjustment for age, gender, race/ethnicity, hypertension, hyperlipidemia, smoking, body mass index, chronic kidney disease, and CRP. Elevated CRP (>3 mg/L) also was strongly associated with PAD (OR, 2.2; 95% CI, 1.3 to 3.6; P=0.003 versus CRP <1 mg/L). Stratifying subjects on the basis of median HOMA-IR, we found that CRP >3 mg/L was no longer significantly associated with PAD in subjects with IR (OR, 1.3; 95% CI, 0.8 to 2.1; P=0.3, P for interaction=0.08).

Conclusions— These findings demonstrate that IR is strongly and independently associated with PAD. Furthermore, IR modifies the association of inflammation with PAD. These data establish a role of IR in PAD and highlight the relative importance of inflammation in patients with and without IR.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 118: 1-2. [Full Text]